Purchase Order 75D30123P17816
Award Date
9/20/23
Potential Completion Date
9/29/24
Potential Value
$55K
Federal Agency
CDC Pittsburgh
Awardee
Genscript USA Inc.
Ultimate Awardee
Not listed
PSC Category
6640 - Laboratory Equipment And Supplies
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Atlanta, GA 30329, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Department of Health and Human Services Centers for Disease Control and Prevention (CDC) awarded a firm fixed-price purchase order contract worth $246,699.00 to Genscript USA Inc., a for-profit biotechnology company. The contract is for the synthesis of plasmids and mutagenesis in support of research on critical vaccine viruses (CVV), with a completion date of September 22, 2024. Genscript, based in Piscataway, New Jersey, provides a range of molecular biology services to federal agencies,...
This is a firm fixed-price purchase order awarded by the Centers for Disease Control and Prevention (CDC) to GenScript USA Inc., a biotechnology company based in New Jersey. The contract is for the supply of synthetic DNA sequences for cell culture expression of monoclonal antibodies to mumps virus, with a ceiling value of $75,024.01 and a period of performance through April 28, 2020. The award was made using a sole-source authority, as the government determined GenScript was the only source...
This federal contract awarded by the Department of Health and Human Services Centers for Disease Control and Prevention (HHS/CDC) to Genscript USA Inc., a for-profit biotechnology company, provides gene synthesis services. The $245,750.00 firm-fixed-price purchase order has a completion date of September 29, 2021 and was awarded on August 18, 2020. The contract does not have a set-aside designation. Genscript is a provider of gene synthesis, gene editing, custom protein and antibody...
This $227,348.40 firm fixed-price purchase order was awarded by the Centers for Disease Control and Prevention (CDC) to Genscript USA Inc., a biotechnology company based in Piscataway, New Jersey. The contract is for the production of focused antibodies and DNA to support the CDC's Influenza Division in the development and characterization of Candidate Vaccine Viruses (CVVs) for influenza pandemic preparedness. This requirement is driven by the constant genetic changes in circulating and novel...
This firm fixed-price purchase order was awarded by the Department of Health and Human Services Centers for Disease Control and Prevention to Genscript USA Inc., a for-profit biotechnology company, for the development of murine hybridoma and V region sequencing. The contract has a potential value of $174,903.00 and a completion date of July 14, 2021. Genscript is a provider of gene synthesis, gene editing, custom protein and antibody production, and other molecular biology services, which it has...
The Department of Health and Human Services Centers for Disease Control and Prevention awarded a $248,857.00 Firm Fixed Price purchase order to Genscript USA Inc., a biotechnology company, for the provision of "FAST GENE SYNTHESIS" services. The contract has an August 7, 2023 completion date and was awarded on August 8, 2022. Genscript is a for-profit organization that provides gene synthesis, gene editing, custom protein and antibody production, and other molecular biology services to...
This firm fixed-price purchase order was awarded by the Centers for Disease Control and Prevention (CDC) to Genscript USA Inc., a biotechnology company based in Piscataway, New Jersey. The $96,751.91 contract is for the provision of custom antigens to support assay development work. The award has no set-aside designation. Genscript specializes in supplying a range of molecular biology products and services to various federal agencies, including the Department of Health and Human Services. The...
The Department of Health and Human Services (HHS) Centers for Disease Control and Prevention (CDC) awarded a firm-fixed-price purchase order contract to Genscript USA Inc., a for-profit biotechnology company, for gene synthesis services. The $163,750 contract has a completion date of September 30, 2019. Genscript is a provider of gene synthesis, gene editing, custom protein and antibody production, and other molecular biology services to support biomedical research and public health...
The Department of Health and Human Services Centers for Disease Control and Prevention awarded a firm-fixed-price purchase order contract to Genscript USA Inc., a for-profit biotechnology company, for stable cell line development services with a completion date of April 1, 2020. The contract had a potential value of $130,400.99 and was not set aside for any particular business type. Genscript provides a range of molecular biology products and services, including gene synthesis, gene editing,...
This is a $10,594.44 firm-fixed-price purchase order awarded by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), a civilian agency within the Department of Health and Human Services (HHS). The contract was awarded to Genscript USA Inc., a for-profit biotechnology company based in Piscataway, New Jersey, without a set-aside designation. The contract requires Genscript to provide a range of molecular biology products and services, including gene synthesis, gene...